B-lymphocyte-mediated delayed cognitive impairment following stroke

Journal of Neuroscience

Volumn 35, Issue 5, 2015, Pages 2133-2145

  Doyle, Kristian P ^a,b   Quach, Lisa N ^a   Solé, Montse ^a,c   Axtell, Robert C ^a   Nguyen, Thuy Vi V ^a,b   Soler Llavina, Gilberto J ^a   Jurado, Sandra ^a   Han, Jullet ^a   Steinman, Lawrence ^a   Longo, Frank M ^a   Schneider, Julie A ^d   Malenka, Robert C ^a   Buckwalter, Marion S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B lymphocyte; Dementia; Immunology; Stroke

Indexed keywords

ANTIBODY; CD20 ANTIBODY; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; Y-MAZE TEST; AGED; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CASE CONTROL STUDY; CEREBRAL ARTERY DISEASE; COMPLICATION; IMMUNOLOGY; LONG TERM POTENTIATION; MAZE TEST; MOUSE; PATHOPHYSIOLOGY;

AGED; ANIMALS; B-LYMPHOCYTE SUBSETS; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; HUMANS; IMMUNOGLOBULINS; INFARCTION, MIDDLE CEREBRAL ARTERY; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 84922363034     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4098-14.2015     Document Type: Article

References (51)

1. Ankeny DP, Popovich PG (2010) B cells and autoantibodies: complex roles in CNS injury. Trends Immunol 31:332–338.CrossRef Medline
2. Ankeny DP, Lucin KM, Sanders VM, McGaughy VM, Popovich PG (2006) Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J Neurochem 99:1073–1087.CrossRef Medline
3. Ankeny DP, Guan Z, Popovich PG (2009) B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest 119:2990-2999.CrossRef Medline
4. Arac A, Brownell SE, Rothbard JB, Chen C, Ko RM, Pereira MP, Albers GW, Steinman L, Steinberg GK (2011) Systemic augmentation of alphaBcrystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A 108:13287–13292.CrossRef Medline
5. Barba R, Martínez-Espinosa S, Rodríguez-García E, Pondal M, Vivancos J, Del Ser T (2000) Poststroke dementia: clinical features and risk factors. Stroke 31:1494-1501.CrossRef Medline
6. Béjot Y, Aboa-Eboulé C, Durier J, Rouaud O, Jacquin A, Ponavoy E, Richard D, Moreau T, Giroud M (2011) Prevalence of early dementia after first-ever stroke: a 24-year population-based study. Stroke 42:607–612.CrossRef Medline
7. Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS (2012a) Overview and findings from the religious orders study. Curr Alzheimer Res 9:628–645.CrossRef Medline
8. Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS (2012b) Overview and findings from the Rush Memory and Aging Project. Curr Alzheimer Res 9:646–663.CrossRef Medline
9. Bernheimer H, Budka H, Müller P (1983) Brain tissue immunoglobulins in adrenoleukodystrophy: a comparison with multiple sclerosis and systemic lupus erythematosus. Acta Neuropathol 59:95–102.CrossRef Medline
10. Bishop GA, Hostager BS (2001) B lymphocyte activation by contactmediated interactions with T lymphocytes. Curr Opin Immunol 13:278–285.CrossRef Medline
11. Boyle PA, Wilson RS, Yu L, Barr AM, Honer WG, Schneider JA, Bennett DA (2013) Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol 74:478–489.CrossRef Medline
12. Carragher DM, Rangel-Moreno J, Randall TD (2008) Ectopic lymphoid tissues and local immunity. Semin Immunol 20:26–42.CrossRef Medline
13. Cerutti A (2008) The regulation of IgA class switching. Nat Rev Immunol 8:421–434.CrossRef Medline
14. Desmond DW, Moroney JT, Sano M, Stern Y (2002) Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33:2254-2260.CrossRef Medline
15. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT (2009) Losing your nerves? Maybe it’s the antibodies. Nat Rev Immunol 9:449–456.CrossRef Medline
16. Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS (2010) TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflammation 7:62.CrossRef Medline
17. Doyle KP, Fathali N, Siddiqui MR, Buckwalter MS (2012) Distal hypoxic stroke: a new mouse model of stroke with high throughput, low variability and a quantifiable functional deficit. J Neurosci Methods 30:31-40.CrossRef Medline
18. Galea I, Bechmann I, Perry VH (2007) What is immune privilege (not)? Trends Immunol 28:12–18.CrossRef Medline
19. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, et al. (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:2672–2713.CrossRef Medline
20. Grillo-López AJ, White CA, Varns C, Shen D, Wei A, McClure A, Dallaire BK (1999) Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 26[Suppl 14]:66-73. Medline
21. Medline Grillo-López AJ, Hedrick E, Rashford M, Benyunes M (2002) Rituximab: ongoing and future clinical development. Semin Oncol 29[1 Suppl 2]: 105–112. CrossRef;/Border http://dx.doi.org/10.1053/sonc.2002.30145 Medline
22. Hattori K, Lee H, Hurn PD, Crain BJ, Traystman RJ, DeVries AC (2000) Cognitive deficits after focal cerebral ischemia in mice. Stroke 31:1939-1944.CrossRef Medline
23. Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80:844-866.CrossRef Medline
24. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA (2004) Dementia after stroke: the Framingham Study. Stroke 35:1264-1268.CrossRef Medline
25. Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T, Austinat M, Nieswandt B, Wiendl H, Stoll G (2010) Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115:3835–3842.CrossRef Medline
26. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT (2004) Cognition and immunity: antibody impairs memory. Immunity 21:179-188.CrossRef Medline
27. Kozakiewicz L, Chen Y, Xu J, Wang Y, Dunussi-Joannopoulos K, Ou Q, Flynn JL, Porcelli SA, Jacobs WR Jr, Chan J (2013) B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response. PLoS Pathogens 9:e1003472.CrossRef Medline
28. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F (2005) Poststroke dementia. Lancet Neurol 4:752–759.CrossRef Medline
29. Lynch MA (2004) Long-term potentiation and memory. Physiol Rev 84:87-136.CrossRef Medline
30. Mărgăritescu O, Mogoanta L, Pirici I, Pirici D, Cernea D, Mărgăritescu C (2009) Histopathological changes in acute ischemic stroke. Rom J Morphol Embryol 50:327–339. Medline
31. Medline Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF (2008) Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118:3420-3430.CrossRef Medline
32. McGeorge AJ, Faull RL (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29:503–537.CrossRef Medline
33. Mena H, Cadavid D, Rushing EJ (2004) Human cerebral infarct: a proposed histopathologic classification based on 137 cases. Acta Neuropathol 108: 524–530.CrossRef Medline
34. Montserrat E (2003) Rituximab in chronic lymphocytic leukemia. Semin Oncol 30:34-39.CrossRef Medline
35. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN (2012) Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol 33:297–305.CrossRef Medline
36. Perosa F, Prete M, Racanelli V, Dammacco F (2010) CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. J Intern Med 267:260-277.CrossRef Medline
37. Prüss H, Iggena D, Baldinger T, Prinz V, Meisel A, Endres M, Dirnagl U, Schwab JM (2012) Evidence of intrathecal immunoglobulin synthesis in stroke: a cohort study. Arch Neurol 69:714-717.CrossRef Medline
38. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, Offner H (2011) Regulatory B cells limitCNSinflammation and neurologic deficits in murine experimental stroke. J Neurosci 31:8556–8563.CrossRef Medline
39. Roström B, Link B (1981) Oligoclonal immunoglobulins in cerebrospinal fluid in acute cerebrovascular disease. Neurology 31:590-596.CrossRef Medline
40. Rubenstein JL, Combs D, Rosenberg J, Levy A, McDermott M, Damon L, Ignoffo R, Aldape K, Shen A, Lee D, Grillo-López A, Shuman MA (2003) Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 101:466–468.CrossRef Medline
41. Savva GM, Stephan BC (2010) Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 41:e41-e46.CrossRef Medline
42. Scher JU (2012) B-cell therapies for rheumatoid arthritis. Bull NYU Hosp Jt Dis 70:200-203. Medline
43. Medline Studer V, Rossi S, Motta C, Buttari F, Centonze D (2014) Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive multiple sclerosis. J Neuroimmunol 276:229-231.CrossRef Medline
44. Tran L, Huitema AD, van Rijswijk MH, Dinant HJ, Baars JW, Beijnen JH, Vogel WV (2011) CD20 antigen imaging with (1)(2)(4)I-rituximab PET/CT in patients with rheumatoid arthritis. Hum Antibodies 20:29-35.CrossRef Medline
45. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O’Brien RJ (2008) Effect of infarcts on dementia in the Baltimore Longitudinal Study of Aging. Ann Neurol 64:168-176.CrossRef Medline
46. Truong DT, Venna VR, McCullough LD, Fitch RH (2012) Deficits in auditory, cognitive, and motor processing following reversible middle cerebral artery occlusion in mice. Exp Neurol 238:114-121.CrossRef Medline
47. Tsementzis SA, Chao SW, Hitchcock ER, Gill JS, Beevers DG (1986) Oligoclonal immunoglobulin G in acute subarachnoid hemorrhage and stroke. Neurology 36:395–397.CrossRef Medline
48. Varallyay CG, Nesbit E, Fu R, Gahramanov S, Moloney B, Earl E, Muldoon LL, Li X, Rooney WD, Neuwelt EA (2013) High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle. J Cereb Blood Flow Metab 33:780-786.CrossRef Medline
49. Vargas ME, Barres BA (2007) Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci 30:153–179.CrossRef Medline
50. Wykes M, MacPherson G (2000) Dendritic cell-B-cell interaction: dendritic cells provide B cells with CD40-independent proliferation signals and CD40-dependent survival signals. Immunology 100:1–3.CrossRef Medline
51. Zhang Y, Da RR, Hilgenberg LG, Tourtellotte WW, Sobel RA, Smith MA, Olek M, Nagra R, Sudhir G, van den Noort S, Qin Y (2005) Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. J Neuroimmunol 167:120-130.CrossRef Medline